Opinions Kash Pashootan
BroadcomAVGOTOP PICKFeb 06, 2018
Kash PashootanStock price when the opinion was issued
As of Jul 02, 2026. Market Open.
You might be interested:
Tried to corner the market by introducing some products that were not as open source, and the market pushed back. That's why it hasn't been able to accelerate its networking business as much as expected. Earnings disappointed. They'll turn it around, more to come on networking. Interesting on this pullback.
She owns players with more upside.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentOur PAST TOP PICK with AVGO has triggered its stop at $378. To remain disciplined, we recommend covering the position at this time. When combined with our previous guidance, this will result in a net investment gain of 2%.
Premium contentIn the last quarter, the company reported 2.05 USD per share, beating the 2.03 USD estimate by 0.93%. Revenue for the same period reached 19.31 B USD, despite the estimate of 19.26 B USD. For the next quarter, analysts expect 2.40 USD in earnings per share and 22.13 B USD in revenue. Social media mentions are up 350% in the past 24h.
Premium contentWe reiterate this developer of semi-conductor chips used in global AI build out as a TOP PICK. They company's accelerator AI chips unlock customer customization that gives it a unique advantage, especially in data center networks. Analysts expect earnings growth over 45% annually for the next 3-5 years. We also like that cash reserves are growing, while debt is retired and shares bought back. We recommend trailing up the stop (from $340) to $378, looking to achieve $498 -- upside potential of 18%. Yield 0.6%
(Analysts’ price target is $479.40)It is second place in the semi conductor space for GPU's and can design them a little cheaper than NVDA. Has owned historically as a good financial model but now more for growth in AI. Has made strong acquisitions and has partnerships with Google and META.
Jamie Murray Premium contentPremium contentAVGO is like the smaller cousin of NVDA. Built GOOG's AI program, increasingly making waves with Anthropic (owns Claude). Interesting, but not a shoot-the-lights-out opportunity. He'd buy.
MRVL is trying to take a share of the chips that go into GOOG, and is already involved with AMZN cloud. Be careful. It's not a given that it's a capable designer of cutting-edge chips. Coin flip. We've been fooled before.
NVDA is actually more interesting than both.
They have the best platform in XPU. That's why they are partnering with Alphabet, Anthropic and now Meta (to reach consumers). The latter is a real, long-term partnership. He's owned this the past 5 years. Consistently grows.
Joe TerranovaLeader. His 12-month price target is $470. Extremely high margins as a designer and manufacturer. Whole spectrum of products. Decent dividend. Significant share buybacks.
Buy here, but leave some space to pick it up a bit lower too. Yield is 0.66%.
Kim BoltonPremium contentWe reiterate AVGO as a TOP PICK. The company announced major partnerships with GOOGLE and Anthropic as each seeks to dramatically grow AI. AVGO produces CPU chips that offer 40% energy consumption reductions -- key for growing data centers. Recently reported earnings showed record revenues (up 29%) and a boost to EPS of 28%. Cash reserves are growing while they retire debt and buy back shares. We recommend trailing up the stop (from $230) to $255, looking to achieve $430 -- over 28% of upside potential. Yield 0.8%
(Analysts’ price target is $460.00)
Broadcom makes chips. It merged with Avgo, which also made chips. The are producing chips across the board, including chips for automobiles and for mobile devices. This business is very capex heavy and is changing rapidly. They have the scale to continuously innovate and pump capital in. The stock trades at 12x earnings with a dividend of $2 (3%). (Analysts' price target is $319.26).